Flunitrazepam does not alter cerebral distribution of buprenorphine in the rat

Toxicology Letters

Volumn 157, Issue 3, 2005, Pages 211-219

  Megarbane, Bruno ^a,b   Pirnay, Stéphane ^a,c   Borron, Stephen W ^a,d   Trout, Hervé ^b   Monier, Claire ^a   Risède, Patricia ^a   Boschi, Gabrielle ^a   Baud, Frédéric J ^a,b  

^a INSERM   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Centre Universitaire des Saints Pères   (France)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Acute toxicity; Arterial blood gases; Buprenorphine; Kinetics; Microdialysis; Respiratory depression

Indexed keywords

BUPRENORPHINE; FLUNITRAZEPAM;

ANIMAL MODEL; ARTERIAL BLOOD; ARTERIAL PH; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; HALF LIFE TIME; MALE; MICRODIALYSIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; STATISTICAL MODEL;

ANIMALS; ANTI-ANXIETY AGENTS; BLOOD GAS ANALYSIS; BUPRENORPHINE; CARBON DIOXIDE; CORPUS STRIATUM; DEPRESSION, CHEMICAL; DRUG INTERACTIONS; FLUNITRAZEPAM; MALE; MICRODIALYSIS; NARCOTIC ANTAGONISTS; PARTIAL PRESSURE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATION;

EID: 19444371788     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2005.02.002     Document Type: Article

References (26)

1. S. Borron, C. Monier, P. Risède, and F.J. Baud Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat Hum. Exp. Toxicol. 21 2002 599 605
2. A. Cowan, J.C. Doxey, and E.J. Harry The animal pharmacology of buprenorphine, an oripavine analgesic agent Br. J. Pharmacol. 60 1977 547 554
3. S. Desrayaud, G. Boschi, R. Rips, and J.M. Scherrmann Dose-dependent delivery of colchicine to the rat hippocampus by microdialysis Neurosci. Lett. 205 1996 9 12
4. 11C-methylbuprenorphine in baboon brain Nucl. Med. Biol. 23 1996 231 325
5. S. Gopal, T.B. Tzeng, and A. Cowan Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine Eur. J. Pharm. Sci. 15 2002 287 293
6. J.B. Gross, R.T. Blouin, S. Zandsberg, P.F. Conard, and J. Haussler Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil Anesthesiology 85 1996 713 720
7. P.N. Gueye, S.W. Borron, P. Risede, C. Monier, F. Buneaux, M. Debray, and F.J. Baud Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat Toxicol. Sci. 62 2001 148 154
8. P.N. Gueye, S.W. Borron, P. Risede, C. Monier, F. Buneaux, M. Debray, and F.J. Baud Buprenorphine and midazolam act in combination to depress respiration in rats Toxicol. Sci. 65 2002 107 114
9. P.N. Gueye, B. Mégarbane, S.W. Borron, F. Adnet, M. Galliot-Guilley, I. Ricordel, F.J. Tourneau, D. Goldgran-Tolédano, and F.J. Baud Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-1999 Addiction 97 2002 1295 1304
10. R.B. Ibrahim, J.G. Wilson, M.E. Thorsby, and D.J. Edwards Effect of buprenorphine on CYP3A activity in rat and human liver microsomes Life Sci. 66 2000 1293 1298
11. T. Kilicarslan, and E.M. Sellers Lack of interaction of buprenorphine with flunitrazepam metabolism Am. J. Psychiatr. 157 2000 1164 1166
12. P. Kintz Deaths involving buprenorphine: a compendium of French cases Foren. Sci. Int. 121 2001 65 69
13. I. Kissin, S.S. Lee, G.R. Arthur, and E.L. Bradley Jr. Effect of midazolam on development of acute tolerance to alfentanil: the role of pharmacokinetic interactions Anesth. Analg. 85 1997 182 187
14. D. Ma, S.M. Sapsed-Byrne, M.K. Chakrabarti, and J.G. Whitwam Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits Acta. Anesth. Scand. 42 1998 670 677
15. G.Y. McCormick, W.J. White, I.S. Zagon, and C.M. Lang Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone J. Pharmacol. Exp. Ther. 230 1984 353 359
16. M. Ohtani, H. Kotaki, K. Nishitateno, Y. Sawada, and T. Iga Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine J. Pharmacol. Exp. Ther. 281 1997 428 433
17. S. Pirnay, S.W. Borron, C.P. Giudicelli, J. Tourneau, F.J. Baud, and I. Ricordel A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths Addiction 99 2004 978 988
18. S. Pirnay, S. Bouchonnet, F. Herve, D. Libong, N. Milan, P. D'Athis, F. Baud, and I. Ricordel Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 807 2004 335 342
19. S.M. Pond, T.G. Tong, N.L. Benovitz, P. Jacob, and J. Rigod Lack of effect of diazepam on methadone metabolism in methadone-maintained addicts Clin. Pharmacol. Ther. 31 1982 139 143
20. M. Reynaud, A. Tracqui, G. Petit, D. Potard, and P. Courty Six deaths linked to misuse of buprenorphine-benzodiazepine combinations Am. J. Psychiatr. 155 1998 448 449
21. N. Shah, V. Patel, and A. Donald Effect of diazepam, desmethylimipramine, and SKF 525-A on the disposition of levo-methadone in mice after single or double injection Drug Metab. Dispos. 7 1979 241 242
22. K.A. Sporer Buprenorphine: a primer for emergency physicians Ann. Emerg. Med. 43 2004 580 584
23. X. Thirion, V. Lapierre, J. Micallef, E. Ronfle, A. Masut, V. Pradel, C. Coudert, J.C. Mabriez, and J.L. Sanmarco Buprenorphine prescription by general practitioners in a French region Drug Alcohol Depend. 65 2002 197 204
24. A. Tracqui, P. Kintz, and B. Ludes Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities J. Anal. Toxicol. 22 1998 430 434
25. K. Umehara, Y. Shimokawa, and G. Miyamoto Inhibition of human drug metabolizing cytochrome P450 by buprenorphine Biol. Pharm. Bull. 25 2002 682 685
26. S.L. Walsh, K.L. Preston, M.L. Stitzer, E.J. Cone, and G.E. Bigelow Clinical pharmacology of buprenorphine: ceiling effects at high doses Clin. Pharmacol. Ther. 55 1994 569 580